Inflarx

Developer of antibody therapeutics for inflammatory and immune diseases

placeJena, Thuringia, Germany calendar_todayFounded 2008 groups56 employees language inflarx.de

Registered entities

Social engagement

Social engagement: 3.4K social following, 9 posts in the last 12 months — above the industry median.

Investor mix

5 investors on record; lead investors include RA Capital Management, Bain Capital Life Sciences.

Investor typeCountShare
Venture capital360%
Bank & private debt120%
Other / undisclosed120%

Recent activity

10 Jun 2026
Event
The Boston Blueprint: Scaling Biotech Across Borders
6 May 2026
Event
izicopan
Coming soon